Titan America has raised $384 million after pricing its U.S. initial public offering at $16 per share, within its targeted ...

"This could have a chilling effect for, conservatively, 12 months, but probably longer," Justin Hall of Golden Gate Ventures ...

Q4 2024 Management View CEO Kyle Gano highlighted Neurocrine's transformation into a fully integrated biopharmaceutical company. He emphasized the strong performance of INGREZZA, which is poised for ...